-Minyanville

Other Tools: Calculators | My Watchlist | My Portfolio

CEPHALON Add to My Watchlist

(NSDQ: CEPH)

Detailed Quote

Last Price	59.61 (11.20.09 5:20 PM EST)
Change (%)	-0.10 (-0.17%)
Volume	1,941,477
Open	59.39
Previous Close	59.71
Day's Range	60.00 - 59.38
Bid / Ask	59.60 / 59.64

Intraday

3 Month

6 Month

1 Year

Average Volume	1,954,220	Shares Outstanding	74.66M
52-Week Range	52.55 - 81.35	Market Cap	4.5B
P/E Ratio	18.1	Earnings Per Share	3.30
Dividend	N/A	Yield	N/A

Symbol	Last	Change (%)
CELG	54.91	+0.36 (+0.66%)
CMXHF	29.40	+0.00 (+0.00)
BIIB	46.38	+0.53 (+1.16%)
GENZ	50.05	+0.42 (+0.85%)
SHPGF	18.50	-0.35 (-1.86%)

Mon, Nov 02, 2009
	Monday's biggest gaining and declining stocks Among the companies whose shares are expected to see active trade in Monday’s session are the European banks as well as CIT, CNA, Dean Foods, Encore Acquisition, Ford, Humana, Loews, Nice, Terra and U.S. Bancorp. - MarketWatch
Mon, Oct 26, 2009
	Stocks in focus for Tuesday Among the shares expected to see active trade in Tuesday’s session are those of Visa, McKesson and TD Ameritrade. - MarketWatch
Thu, Oct 22, 2009
	Israel stocks off: Israel Chemicals, Teva in focus Israeli stocks fall Thursday, as strength in Israel Chemicals and its parent is offset by broad weakness among the blue chips and the tech sector. - MarketWatch
Thu, Aug 06, 2009
	Eight Prescription Drugs with Truly Alarming Side Effects The global pharmaceuticals market is expected to reach $967 billion by 2011 -- which is why companies are always looking for that next must-have drug. Staying profitable and pleasing shareholders means constant innovation but the FDA approval process for a new drug can take over a decade to complete and the cost can exceed $800 million. From there on average only 5 out of every 5 000 will make it to market. And there’s no guarantee any of those 5 will turn a profit. That’s why Big Pharma’s latest innovations aren’t new drugs -- they’re new syndromes and disorders. ... - Minyanville
Tue, Aug 04, 2009
	Stocks in focus for Wednesday Among the stocks expected to see active trading Wednesday are Boyd Gaming, Devon Energy, Orbitz and Ralph Lauren. - MarketWatch
More Featured Content

Thu, Nov 05, 2009
	Pivotal Data Published in the Journal Cancer Demonstrate that TREANDA Induced Durable Responses in Relapsed Indolent Non-Hodgkin's Lymphoma - PR Newswire
Wed, Nov 04, 2009
	Cephalon, Inc. to Webcast R&D Day - PR Newswire
	Critical Alerts for Microsoft, US Steel, Cephalon, Eaton, and Harmony Gold Released by Seven Summits Research - PR Newswire
Mon, Nov 02, 2009
	Mayo Clinic Proceedings Publishes Study of NUVIGIL in Patients with Shift Work Disorder - PR Newswire
Thu, Oct 29, 2009
	Trading Review for Jazz Pharmaceuticals Inc. Issued by Beacon Equity - GlobeNewswire
More Press Releases

11/10/09		Special Conference Cephalon, Inc. 2009 R&D Day Archive for CEPH
10/27/09		Q3 2009 Earnings Archive for CEPH
09/21/09		Special Conference Eleventh Annual UBS Global Life Sciences Conference Archive for CEPH
08/04/09		Q2 2009 Earnings Archive for CEPH
05/05/09		Q1 2009 Earnings Archive for CEPH

Powered By: FinancialContent Services, Inc.
Nasdaq quotes delayed at least 15 minutes.
All other data is delayed at least 20 minutes.
By accessing this page, you agree to the following terms and conditions.
Stock Updates provided by MarketMinute.com
Stock Analysis provided by SocialPicks Conference calls info supplied by OpenCompany
Fundamental data supplied by Mergent, Inc.
Stock quote data supplied by Telekurs

Bio

Bio

Bio

Bio

Bio

Bio

Bio

Bio

Bio

Bio

Bio

Todd Harrison

Terry Woo

Kevin Depew

Jeff Macke

Andrew Jeffery

Jeffrey Cooper

Dr Janice Dorn

Allan Dodds Frank

John Mauldin

Smita Sadana